Adalimumab Improves Symptoms of Axial Spondyloarthritis Medscape More than one third of patients treated with adalimumab had at least 40% improvement on the standard Assessments in Ankylosing Spondylitis (ASAS40) measure compared with 14.9% of placebo recipients (P < .001). "We showed that on standard measures, ...
Home Care Health Inspections Lag In Ct, Fines Rarely Imposed Connecticut Watchdog “Nine,” replies Tabor, who suffers from a rare spinal disease, ankylosing spondylitis, which has taken away her ability to walk, swallow or turn her head completely. Perhaps the most remarkable thing about this treatment is that it's happening in ...